Cargando…
Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria
Introduction. Several point-of-care tests (POCT) are available for the diagnosis of bladder cancer (BC). We evaluate the impact of HU (hematuria) on performance of POCTs. Materials and Methods. Urine from 10 donors was diluted with blood from 0.5 to 0.00625%. BladderCheck(R), BTAstat(R), BCM(R), and...
Autores principales: | Hennenlotter, Joerg, Huber, Severine, Todenhöfer, Tilman, Kuehs, Ursula, Schilling, David, Aufderklamm, Stefan, Gakis, Georgios, Schwentner, Christian, Stenzl, Arnulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227231/ https://www.ncbi.nlm.nih.gov/pubmed/22162681 http://dx.doi.org/10.1155/2011/937561 |
Ejemplares similares
-
Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study
por: Horstmann, Marcus, et al.
Publicado: (2014) -
Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2015) -
Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014) -
Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer – 5-year experience in a single-center
por: Seibold, Joerg, et al.
Publicado: (2011) -
Assessment of a new point-of-care system for detection of prostate specific antigen
por: Rausch, Steffen, et al.
Publicado: (2016)